Join Us in the Fight Against Breast Cancer October is Breast Cancer Awareness Month, and Clinical Services International (CSI) is proudly wearing pink to show our solidarity with this vital cause. Breast cancer affects millions of lives each year. This month serves as a reminder of the importance of awareness, early detection, and support for those impacted by this disease. Pink is not just a colour; it is a symbol of hope and resilience. By wearing pink, we express our suppo

Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation. Challenge There were several key

At CSI, we’ve built our reputation on being a trusted partner in advancing global health. Among our proudest achievements is our role in...

When it comes to sourcing medicines for Acute Myeloid Leukemia (AML), a supply partner with experience is imperative. At CSI, we’ve built...

At CSI, we understand the urgency and precision required in ophthalmology research. Among the most pressing areas is wet age-related macular degeneration (AMD) a leading cause of vision loss worldwide. Clinical studies in this field demand not only specialized medicines, but also a reliable partner who can ensure seamless supply and global reach. With direct access to all major manufacturers, a fully scientific project team, and a proven track record across ophthalmology prog

Strategy Partnerships for Budget Value As we enter Q4, many clinical operations teams face the familiar challenge of budget utilization. In research-driven organizations, unspent funds create pressure to allocate resources quickly. Yet, reactive decisions can compromise study timelines, inflate costs, or affect compliance. The question becomes: how can sponsors and CROs transform year-end budget pressures into a strategic advantage? From Short-Term Spending to Strategic Inves

Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer patients, limited historical data and small global treatment populations, every component of the trial must be executed with precision, especially the sourcing of comparator drugs and ancillary supplies. In rare disease studies patient recruitment is already difficult. Delays due to drug unavailability or supply chain inefficiencies can have a

On November 4th-5th, join CSI’s Managing Director, Vanessa Dekou and Head of Operations, North America, Jonathan Miller at the...

Join us on October 15–16 at the Encore Boston Harbor, MA, for one of the leading events in clinical trial operations, Outsourcing in...

From 14 th -16th October, join CSI's representatives at The Corinthia, Budapest for the leading clinical supply chain event, GCSG Europe...

On 17th–18th September, our Director of Project Management, Stephan Muetze, and Project Manager, Aylin Asadian, will be on-site at the Messe, Düsseldorf, to discuss all things relating to clinical trial supply; from global sourcing to product access and logistics. If you’re attending, come and connect with us to explore how CSI can support your next study.